Crossmark

Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence

Crossref DOI link: https://doi.org/10.1016/j.htct.2026.106459

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cançado, Rodolfo Delfini https://orcid.org/0000-0003-3269-3780
de Melo Campos, Paula https://orcid.org/0000-0002-2971-7203
Kashiura, Diego https://orcid.org/0000-0001-7275-6358
Thies, Felipe https://orcid.org/0009-0001-9258-7368
Ferreira, Erica https://orcid.org/0009-0006-0985-5664
de Almeida, Ana Beatriz Machado https://orcid.org/0000-0001-9111-1360
Leonel, Lays Paulino https://orcid.org/0000-0003-1529-0488
Cortez, Lucas Vieira https://orcid.org/0000-0001-7762-1997
Melo, Nina https://orcid.org/0000-0002-7951-1019
Fedozzi, Fabio https://orcid.org/0009-0002-2995-2446
Bigoni, Alessandro https://orcid.org/0000-0002-2483-3299
Funding

Funding for this research was provided by:

Novartis AG
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-04-09
More Information

This article is maintained by: Elsevier

Article Title: Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2026.106459

Content Type: article

Copyright: © 2026 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.